Manchikanti, Laxmaiah;
Kaye, Adam M;
Knezevic, Nebojsa Nick;
Giordano, James;
Applewhite, Megan K;
Bautista, Alexander;
Soin, Amol;
Blank, Susan K;
Sanapati, Mahendra R;
Karri, Jay;
Christo, Paul J;
Abd-Elsayed, Alaa;
Kaye, Alan D;
Calodney, Aaron;
Navani, Annu;
Gharibo, Christopher G;
Harned, Michael;
Gupta, Mayank;
Broachwala, Mustafa;
Sehgal, Nalini;
Kaufman, Andrew;
Wargo, Bradley;
Solanki, Daneshvari R;
Hsu, Eric S;
Limerick, Gerard;
Dennis, Allen;
Swicegood, John R;
Slavin, Konstantin;
Snook, Lee;
Pasupuleti, Ramarao;
Kosanovic, Radomir;
Justiz, Rafael;
Barkin, Robert;
Atluri, Sairam;
Shah, Shalini;
Pampati, Vidyasagar;
Helm II, Standiford;
Grami, Vahid;
Myckowiak, Vicki;
Galan, Vincent;
Singh, Vijay;
Manocha, Vivek;
Hirsch, Joshua A.
Opioid prescribing in the United States is decreasing, however, the opioid epidemic
is continuing at an uncontrollable rate. Available data show a significant number of opioid deaths,
primarily associated with illicit fentanyl use. It is interesting to also note that the data show no
clear correlation be...
Bell, Alan D;
MacCallum, Caroline;
Margolese, Shari;
Walsh, Zach;
Wright, Patrick;
Daeninck, Paul J;
Mandarino, Enrico;
Lacasse, Gary;
Deol, Jagpaul Kaur;
Freitas, Lauren de;
St. Pierre, Michelle;
Belle-Isle, Lynne;
Gagnon, Marilou;
Bevan, Sian;
Sanchez, Tatiana;
Arlt, Stephanie;
Monahan-Ellison, Max;
O'Hara, James;
Boivin, Michael;
Costiniuk, Cecilia.
One in five individuals live with chronic pain globally, which often co-occurs with sleep problems, anxiety, depression, and substance use disorders. Although these conditions are commonly managed with cannabinoid-based medicines (CBM), health care providers report lack of information on the risks, benef...
Sandbrink, Friedhelm;
Murphy, Jennifer L;
Johansson, Melanie;
Olson, Juli L;
Edens, Ellen;
Clinton-Lont, Jamie;
Sall, James;
Spevak, Christopher;
Brown, Nicole;
Guinta, Raquel;
Macedo, Franz;
Nazario, Mitchell;
Pangarkar, Sanjog;
Preston, Samuel;
Prince, Matthew;
Real, Donna Endsley;
Riegleman, David;
Steil, Evan.
In May 2022, leadership within the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the use of opioids when managing chronic pain. This synopsis summarizes the recommendations that the authors believe are the most important to ...
Clinical question: What is the role of medical cannabis or cannabinoids for people living with chronic pain due to cancer or non-cancer causes?
Current practice: Chronic pain is common and distressing and associated with considerable socioeconomic burden globally. Medical cannabis is increasingly used t...
This guideline covers assessing all chronic pain (chronic primary pain, chronic secondary pain, or both) and managing chronic primary pain in people aged 16 years and over. Chronic primary pain is pain with no clear underlying cause, or pain (or its impact) that is out of proportion to any observable inj...
Chronic Pain/classification,
Chronic Pain/drug therapy,
Chronic Pain/prevention & control,
Antidepressive Agents/therapeutic use,
Medical Marijuana/therapeutic use,
Analgesics, Opioid/therapeutic use,
Benzodiazepines/therapeutic use,
Anticonvulsants/therapeutic use,
Anesthetics, Local/therapeutic use,
Adrenal Cortex Hormones/therapeutic use,
Acupuncture Therapy
This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy....
Busse, J. W;
Craigie, S;
Juurlink, D. N;
Buckley, D. N;
Wang, L;
Couban, R. J;
Agoritsas, T;
Akl, E. A;
Carrasco-Labra, A;
Cooper, L;
Cull, C;
Costa, B. R. da;
Frank, J. W;
Grant, G;
Iorio, A;
Persaud, N;
Stern, S;
Tugwell, P;
Vandvik, P. O;
Guyatt, G. H.
Guideline for opioid therapy and chronic noncancer pain: the objective is to inform the prescribing of opioids for adults with chronic noncancer pain....
